Mind Medicine MindMed News - MNMD

Company Name	Stock Ticker Symbol	Market	Type
Mind Medicine MindMed Inc	MNMD	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.31	-3.49%	8.56	19:59:17

Open Price	Low Price	High Price	Close Price	Prev Close
9.04	8.42	9.04	8.46	8.87

more quote information »

Recent News

Date	Time	Source	Heading
4/02/2024	07:00	BW	MindMed to Present at Upcoming April Medical Conferences
4/01/2024	17:00	BW	MindMed Announces Voluntary Delisting from Cboe Canada
3/11/2024	08:32	EDGAR2	Form 8-K - Current report
3/11/2024	07:00	BW	MindMed to Participate in the Leerink Partners 2024 Global..
3/07/2024	08:19	EDGAR2	Form 8-K - Current report
3/07/2024	07:13	BW	Mind Medicine (MindMed) Inc. Announces Pricing of..
3/07/2024	07:09	EDGAR2	Form S-3MEF - Registration adding securities to prior Form..
3/07/2024	06:56	EDGAR2	Form 8-K - Current report
3/07/2024	06:00	BW	MindMed Receives FDA Breakthrough Therapy Designation and..
3/01/2024	13:56	EDGAR2	Form 144 - Report of proposed sale of securities
3/01/2024	09:00	BW	MindMed to Host Conference Call and Webcast to Discuss Data..
2/29/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	16:45	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/28/2024	07:20	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/28/2024	07:15	EDGAR2	Form 8-K - Current report
2/28/2024	07:05	BW	MindMed Reports 2023 Financial Results and Business Updates
2/22/2024	07:00	BW	MindMed to Host Conference Call and Webcast to Discuss 2023..
2/07/2024	07:00	BW	MindMed to Participate in the 34th Annual Oppenheimer..
1/08/2024	08:00	EDGAR2	Form 8-K - Current report
1/08/2024	07:45	BW	MindMed Announces Business Update and Anticipated Milestones..
12/26/2023	16:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	16:50	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	16:44	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
12/26/2023	16:24	EDGAR2	Form 144 - Report of proposed sale of securities
12/14/2023	07:57	EDGAR2	Form 8-K - Current report
12/14/2023	07:30	BW	MindMed Announces Positive Topline Results from Phase 2b..
11/02/2023	16:20	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	16:15	EDGAR2	Form 8-K - Current report
11/02/2023	16:01	BW	MindMed Reports Third Quarter 2023 Financial Results and..
10/26/2023	07:30	BW	MindMed to Host Conference Call and Webcast to Discuss Third..
10/24/2023	07:30	BW	MindMed Completes Enrollment of Phase 2a Trial of MM-120 in..
10/03/2023	07:30	BW	MindMed to Present Data on the Preclinical Activity of..
9/25/2023	21:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/25/2023	21:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/25/2023	21:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/25/2023	21:02	EDGAR2	Form 144 - Report of proposed sale of securities
9/25/2023	21:01	EDGAR2	Form 144 - Report of proposed sale of securities
9/25/2023	21:01	EDGAR2	Form 144 - Report of proposed sale of securities
9/15/2023	17:27	EDGAR2	Form 8-K/A - Current report: [Amend]
9/15/2023	17:23	EDGAR2	Form 8-K/A - Current report: [Amend]
9/14/2023	07:30	BW	MindMed to Participate in the TD Cowen 3rd Annual Novel..
9/12/2023	07:30	BW	MindMed Completes Enrollment of Phase 2b Trial of MM-120 in..
8/28/2023	20:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/28/2023	10:35	EDGAR2	Form 144 - Report of proposed sale of securities
8/28/2023	09:16	EDGAR2	Form 144 - Report of proposed sale of securities
8/28/2023	07:30	BW	MindMed to Participate at September Investor Conferences
8/14/2023	08:31	EDGAR2	Form 8-K - Current report
8/14/2023	07:30	BW	MindMed Secures $50.0 Million Credit Facility with K2..